Skip to main content

Table 2 Mortality rate ratios for death from cancer, associated with prior cutaneous squamous cell carcinoma in persons diagnosed with cancer of the lung, colon, rectum, breast, prostate, or non-Hodgkin's lymphoma (NHL) in Denmark 1982-2003

From: Mortality in cancer patients with a history of cutaneous squamous cell carcinoma - a nationwide population-based cohort study

 

Unadjusted

MRR (95% CI)

Adjusteda

MRR (95% CI)

Lung cancer

1.27 (1.09-1.48)

1.23 (1.05-1.43)

Colon cancer

1.31 (1.06-1.61)

1.13 (0.92-1.40)

Rectal cancer

1.53 (1.19-1.98)

1.29 (1.00-1.67)

Breast cancer

1.37 (1.05-1.81)

1.09 (0.82-1.43)

Prostate cancer

1.11 (0.93-1.32)

0.97 (0.81-1.15)

NHLb

1.46 (1.09-1.96)

1.09 (0.81-1.47)

Overall

1.24 (1.14-1.35)

1.13 (1.04-1.23)

  1. CI: confidence interval
  2. aAll estimates are adjusted for age group, age group divided by exact age for each individual, gender, Charlson comorbidity index (low, medium, high), calendar period (1982-1986, 1987-1991, 1992-1996, 1997-2001, 2002-2003), a history of any autoimmune disease (yes/no), stage (localized, regional, distant, or unknown/missing), and the following index cancer treatments: no/symptomatic, chemotherapy, radiation therapy, hormone therapy, operation, and other/missing treatment
  3. bIncludes the phenotypic variant chronic lymphocytic leukemia